Published in Nouv Rev Fr Hematol on January 01, 1989
Frequent factor II G20210A mutation in idiopathic portal vein thrombosis. Gastroenterology (1999) 2.66
Invisible mycosis fungoides: A diagnostic challenge. J Am Acad Dermatol (2000) 2.52
Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest (1999) 2.34
Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene. J Clin Invest (1984) 2.07
Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens). Proc Natl Acad Sci U S A (1987) 1.82
Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med (2001) 1.75
The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett (1997) 1.70
Genetic screening for hemophilia A (classic hemophilia) with a polymorphic DNA probe. N Engl J Med (1985) 1.67
Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. Eur J Pharmacol (2001) 1.59
A measles outbreak in children under 15 months of age in La Rioja, Spain, 2005-2006. Euro Surveill (2006) 1.59
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br J Haematol (1995) 1.55
The clinical dementia rating sum of box score in mild dementia. Dement Geriatr Cogn Disord (2005) 1.54
The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation. Blood (1998) 1.48
Prevalence and significance of anticardiolipin antibodies in Crohn's disease. Dig Dis Sci (1994) 1.47
Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane-active drugs. Lab Invest (1979) 1.44
Sensitivity and long-term prognostic value of cardiac troponin-I increase shortly after percutaneous transluminal coronary angioplasty. Clin Cardiol (1998) 1.43
Lactate Dehydrogenases in Human Testes. Science (1963) 1.39
[Acrosyndromes induced by bleomycin in HIV 1 related Kaposi's disease. 5 cases]. Presse Med (1997) 1.39
[Meningoencephalitis: an unusual complication of influenza vaccine]. Med Clin (Barc) (1999) 1.39
[Clinical manifestations of myotonic dystrophy: epidemiologic survey]. Med Clin (Barc) (1993) 1.38
[Jugular thrombosis and adenocarcinoma of the prostate: a state of hypercoagulability?]. An Med Interna (1998) 1.38
Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187. J Lab Clin Med (1977) 1.35
Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J Exp Med (1998) 1.31
Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost (2005) 1.25
In vitro and in vivo functions of thrombin-treated platelets. Thromb Haemost (1976) 1.22
Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors. Thromb Haemost (2000) 1.21
Cloning and expression of a cDNA coding for the anticoagulant hirudin from the bloodsucking leech, Hirudo medicinalis. Proc Natl Acad Sci U S A (1986) 1.20
Ontogeny of B-lymphocyte differentiation induced by pokeweed mitogen. Clin Immunol Immunopathol (1976) 1.20
Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother (2008) 1.19
HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. J Clin Invest (1999) 1.18
Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist. Circulation (2001) 1.17
Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46,XY disorder of sex development. J Clin Endocrinol Metab (2010) 1.16
Clq inhibition of the interaction of collagen with human platelets. J Immunol (1976) 1.16
The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel. Br J Haematol (1998) 1.15
The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin--a phosphoinositide 3-kinase-dependent mechanism. FEBS Lett (2001) 1.15
Antibody responses in early human immunodeficiency virus type 1 infection in hemophiliacs. J Infect Dis (1988) 1.15
Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell lines. Thromb Haemost (1997) 1.14
Arterial thrombosis and protein S deficiency. Thromb Haemost (1989) 1.13
Effect of recent thymic emigrants on progression of HIV-1 disease. Lancet (2000) 1.13
The human platelet ADP receptor activates Gi2 proteins. Biochem J (1995) 1.12
Effects on platelet function of removal of platelet sialic acid by neuraminidase. Lab Invest (1975) 1.12
ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Galphaq. Blood (2000) 1.12
Adherence of platelets to a collagen-coated surface: development of a quantitative method. J Lab Clin Med (1973) 1.12
International conference on the healthy effect of virgin olive oil. Eur J Clin Invest (2005) 1.12
Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype). Blood (1989) 1.09
Characterization of CD1e, a third type of CD1 molecule expressed in dendritic cells. J Biol Chem (2000) 1.09
Activation of ADP receptors and platelet function. Thromb Haemost (1997) 1.09
Thrombin regulates tissue factor and thrombomodulin mRNA levels and activities in human saphenous vein endothelial cells by distinct mechanisms. J Biol Chem (1993) 1.08
Effects of penicillin G on platelet aggregation, release, and adherence to collagen. Proc Soc Exp Biol Med (1973) 1.07
CD1 expression is not affected by human peptide transporter deficiency. Hum Immunol (1994) 1.07
Properties of washed human platelets. Thromb Haemost (1977) 1.07
A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-A*01 allele. Tissue Antigens (1997) 1.05
Bordetella hinzii, a "new" opportunistic pathogen to think about. J Infect (2000) 1.05
Properties of the testicular lactate dehydrogenase isoenzyme. Biochem J (1976) 1.05
Genetic and physical mapping of new EST-derived SSRs on the A and B genome chromosomes of wheat. Theor Appl Genet (2009) 1.05
Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry. Biochemistry (2000) 1.03
An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity--a mechanism for thrombosis. Thromb Haemost (1986) 1.03
Evidence for cross-talk between glycoprotein VI and Gi-coupled receptors during collagen-induced platelet aggregation. Blood (2001) 1.02
A simple in vitro model of mechanical injury of confluent cultured endothelial cells to study quantitatively the repair process. Thromb Haemost (1986) 1.01
Waste management from pulp and paper production in the European Union. Waste Manag (2008) 1.01
Littoral cell angioma of the spleen: US and MR imaging findings. Abdom Imaging (1999) 1.01
A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation. J Clin Invest (1992) 1.00
Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation. Atherosclerosis (2006) 0.99
ADP receptor induced activation of guanine nucleotide binding proteins in rat platelet membranes--an effect selectively blocked by the thienopyridine clopidogrel. Thromb Haemost (1992) 0.99
Tissue and substrate specificity of inhibition by alkoxy-aryl-lactams of platelet and arterial smooth muscle cyclic nucleotide phosphodiesterases relationship to pharmacological activity. Biochem Biophys Res Commun (1983) 0.99
Epidemiology of haemophilia in Greece: an overview. Thromb Haemost (1994) 0.99
South-polar features on Venus similar to those near the north pole. Nature (2007) 0.98
Cloning and characterization of the gene encoding the human platelet glycoprotein V. A member of the leucine-rich glycoprotein family cleaved during thrombin-induced platelet activation. J Biol Chem (1993) 0.98
Thin-layer chromatography of human platelet phospholipids with fatty acid analysis. J Chromatogr (1987) 0.98
Association of the testicular lactate dehydrogenase isozyme with a special type of mitochondria. Biol Reprod (1972) 0.98
Prenylflavonoids and prenyl/alkyl-phloroacetophenones: synthesis and antitumour biological evaluation. Eur J Med Chem (2010) 0.97
An unusual pectate lyase from a Bacillus sp. with high activity on pectin: cloning and characterization. Microbiology (2000) 0.97
Human epidermal Langerhans cells internalize by receptor-mediated endocytosis T6 (CD1 "NA1/34") surface antigen. Birbeck granules are involved in the intracellular traffic of the T6 antigen. J Invest Dermatol (1987) 0.97
Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits. Thromb Haemost (1991) 0.97
Effect of inhibitors of the arachidonate pathway on the release of granule contents from rabbit platelets adherent to collagen. Lab Invest (1980) 0.97
Circulating procoagulant microparticles in obesity. Diabetes Metab (2006) 0.97
Intussusception: the accuracy of ultrasound-guided saline enema and the usefulness of a delayed attempt at reduction. J Pediatr Surg (1999) 0.96
Cloning and sequencing of a human cDNA encoding endothelial P2Y1 purinoceptor. Gene (1996) 0.96
Rapid isolation of human endothelial cells from whole blood using S-Endo1 monoclonal antibody coupled to immuno-magnetic beads: demonstration of endothelial injury after angioplasty. Thromb Haemost (1992) 0.95
Intracellular pathway for the generation of functional MHC class II peptide complexes in immature human dendritic cells. J Immunol (1998) 0.95
Isozymes: biological and clinical significance. Pediatrics (1966) 0.95
Characterization of Trypanosoma cruzi populations by zymodemes: correlation with clinical picture. Am J Trop Med Hyg (1996) 0.95
Intracellular localization of the testicular and sperm-specific lactate dehydrogenase isozyme C4 in mice. Biol Reprod (1995) 0.95
Lupus-like anticoagulants, modulation of the protein C pathway and thrombosis. Thromb Haemost (1987) 0.95
ADP induced blood platelet activation: a review. Nouv Rev Fr Hematol (1991) 0.95
Active gamma-carboxylated human factor IX expressed using recombinant DNA techniques. Nature (1985) 0.95
Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. Blood (2001) 0.94
The alpha(IIb)beta(3) integrin and GPIb-V-IX complex identify distinct stages in the maturation of CD34(+) cord blood cells to megakaryocytes. Blood (2000) 0.94